|
Nutra Pharma, through its subsidiary ReceptoPharm,
has a pipeline of biopharmaceutical products under
development. These research and development pipeline
products consist of several novel therapies in
various stages of development to prevent and/or
treat multiple sclerosis, HIV/AIDS, adrenomyeloneuropathy,
rabies, herpes, rheumatoid arthritis and pain.
|
Drug |
Indication |
Pre-clinical |
Phase
I |
Phase
II |
Phase
III |
Marketing |
| |
MS |
|
|
|
|
|
| |
AMN |
|
|
|
|
|
| |
HIV |
|
|
|
|
|
| |
Herpes |
|
|
|
|
|
| |
Rabies |
|
|
|
|
|
| |
RA |
|
|
|
|
|
| RPI-78 |
Pain |
|
|
|
|
|
| RPI-70 |
Pain |
|
|
|
|
|
|
| |
Completed |
|
| |
Planning |
|
| |
In Progress |
|
|
|
|
